Cargando…

The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer

At present, the standard treatment approach for locally advanced cervical cancer is concurrent chemoradiotherapy (CCRT). An elevated pretreatment squamous cell carcinoma antigen (SCC Ag) level is associated with extensive tumors and poor survival for patients with cervical cancer treated with defini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jingxuan, Wang, Weiping, Wang, Yidan, Liu, Chengeng, Wang, Peichang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694518/ https://www.ncbi.nlm.nih.gov/pubmed/31416463 http://dx.doi.org/10.1186/s13014-019-1355-4

Ejemplares similares

Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy
por: Zhang, Guangyu, et al.
Publicado: (2021)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
por: Hu, Ge, et al.
Publicado: (2023)

CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma
por: Zhang, Jingya, et al.
Publicado: (2022)

Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors
por: Guo, Hong-tao, et al.
Publicado: (2020)

Radiation-Induced Uterine Carcinosarcoma after Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma
por: Moreira-Barros, Joana, et al.
Publicado: (2018)

Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage
por: Xu, Fan, et al.
Publicado: (2018)

Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer
por: Yoo, Ji Geun, et al.
Publicado: (2022)

Using SCC Antigen and CRP Levels as Prognostic Biomarkers in Recurrent Oral Cavity Squamous Cell Carcinoma
por: Chen, I-How, et al.
Publicado: (2014)

Assessment of the relationship between serum squamous cell carcinoma antigen (SCC-Ag) concentration in patients with locally advanced squamous cell carcinoma of the uterine cervix and the risk of relapse
por: Kubik, Sylwester, et al.
Publicado: (2019)

Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma
por: Adel, Mohamad, et al.
Publicado: (2016)

Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
por: Hu, Ke, et al.
Publicado: (2018)

Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy
por: Yoon, Sang Min, et al.
Publicado: (2010)

Preliminary study on the function of the POLD1 (CDC2) EXON2 c.56G>A mutation
por: Liu, Jing, et al.
Publicado: (2020)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis
por: Zhang, Lijuan, et al.
Publicado: (2015)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis
por: Choi, Kyu Hye, et al.
Publicado: (2018)

Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Tanaka, Keiichi, et al.
Publicado: (2020)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis
por: Lan, Mei, et al.
Publicado: (2017)

Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
por: Wang, Weiping, et al.
Publicado: (2017)

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients
por: Borman, Sherri, et al.
Publicado: (2022)

MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma
por: Wu, Youyi, et al.
Publicado: (2022)

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
por: Ho, Yu-Chieh, et al.
Publicado: (2023)

Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis
por: Wen, Xin, et al.
Publicado: (2020)

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
por: Huang, Eng-Yen, et al.
Publicado: (2012)

Reference intervals for thyroid hormones for the elderly population and their influence on the diagnosis of subclinical hypothyroidism
por: Fu, Jingxuan, et al.
Publicado: (2023)

Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma
por: Cao, Xun, et al.
Publicado: (2012)

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
por: Huang, Pei-Wei, et al.
Publicado: (2018)

Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
por: Meng, Qingyu, et al.
Publicado: (2022)

Cutaneous squamous cell carcinoma (SCC) arising in stump of amputated finger in a patient with resected glossal SCC
por: Uchida, Kenzo, et al.
Publicado: (2012)

Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy
por: Wang, Yan-Yang, et al.
Publicado: (2016)

Squamous cell carcinoma (SCC) arising in esophageal colon interposition
por: Taslimi, Reza, et al.
Publicado: (2017)

Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
por: Zhou, Xi‐Lei, et al.
Publicado: (2019)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma
por: Bai, Zhou-lan, et al.
Publicado: (2012)

A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
por: Zhao, Chuanhua, et al.
Publicado: (2016)

Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
por: Chen, Wenjuan, et al.
Publicado: (2022)

ANTI-CANCER ACTIVITY OF ASTER TATARICUS ON SCC-9 HUMAN ORAL SQUAMOUS CARCINOMA
por: Wang, Rui, et al.
Publicado: (2017)

Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis
por: Wang, Weiping, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vq0s9rhrjoo5k500l5e863k86n